Phytotherapy in psychiatry: why psychiatrists should know about it

被引:0
|
作者
Lacerda, Guilherme Frederico Miranda [1 ]
Oliviera, Paulo Cesar [1 ]
Vital, Maria Aparecida Barbato Frazao [1 ]
Slomp Junior, Helvo [2 ]
Galduroz, Jose Carlos Fernandes [3 ]
Andreatini, Roberto [1 ]
机构
[1] Univ Fed Parana, Dept Pharmacol, Curitiba, Parana, Brazil
[2] Fed Univ Rio de Janeiro UFRJ, Inst Med Sci, UFRJ Macae, Dept Publ Mental & Family Hlth Multidisciplinary C, Macae, RJ, Brazil
[3] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, SP, Brazil
关键词
Adverse effects; herb-drug interactions; mental disorders; phytotherapy; psychiatry; ALTERNATIVE MEDICINE CAM; MENTAL-DISORDERS; UNITED-STATES; DOUBLE-BLIND; COMPLEMENTARY; PREVALENCE; DEPRESSION; ADULTS; POPULATION; THERAPIES;
D O I
10.1017/neu.2024.25
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is a substantial use of Complementary and Alternative Medicine (CAM) among both the general population and psychiatric patients, with only a minority of these users disclosing this information to their healthcare providers, including physicians and psychiatrists. This widespread use of CAM can impact positively or negatively on the clinical outcomes of psychiatric patients, and it is often done along with conventional medicines. Among CAM, phytotherapy has a major clinical relevance due to the introduction of potential adverse effects and drug interactions. Thus, the psychiatrist must learn about phytotherapy and stay up-to-date with solid scientific knowledge about phytotherapeutics/herbal medicines to ensure optimal outcomes for their patients. Furthermore, questions about herbal medicines should be routinely asked to psychiatric patients. Finally, scientifically sound research must be conducted on this subject.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [1] WHAT PSYCHIATRISTS SHOULD KNOW ABOUT THE LIMITATIONS OF LAW
    FOSTER, HH
    WISCONSIN LAW REVIEW, 1965, (02) : 189 - 239
  • [2] It is essential for neurologists to know about psychiatry, in the same way, it is essential for psychiatrists to know about neurology
    Ruiz-Garcia, Ramiro
    REVISTA MEXICANA DE NEUROCIENCIA, 2023, 24 (05): : 129 - 130
  • [3] Why should psychiatrists learn about narrative therapy?
    Jensen, Povl E. B.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 (09): : 709 - 711
  • [4] What Psychiatrists Should Know about Dialectical Behavior Therapy
    Linehan, Marsha M.
    PSYCHIATRIC ANNALS, 2013, 43 (04) : 148 - 148
  • [5] WHY YOU SHOULD KNOW ABOUT THE AHCPR
    KURITZKY, L
    HOSPITAL PRACTICE, 1994, 29 (09): : 53 - 54
  • [6] WHAT DO NON-PSYCHIATRISTS NEED TO KNOW ABOUT PSYCHIATRY?
    Rotstein, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 120 - 120
  • [7] Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
    Moreira, Estefania Gastaldello
    Boll, Karine Maria
    Correia, Dalmo Guilherme
    Soares, Janaina Favaro
    Rigobello, Camila
    Maes, Michael
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (11) : 1004 - 1020
  • [8] WHY SHOULD PSYCHIATRISTS WORRY ABOUT METABOLIC SYNDROME IN THEIR PATIENTS?
    L'Italien, Gilbert
    CLINICAL NEUROPSYCHIATRY, 2006, 3 (05): : 299 - 301
  • [9] What Psychiatrists Should Know About Prescribed Safer Opioid Supply
    Bahji, Anees
    Danilewitz, Marlon
    Sachdev, Arushi
    Mathew, Nickie
    Lamba, Wiplove
    Rafizadeh, Reza
    Chopra, Nitin
    Dhaliwal, Arash
    George, Tony P.
    Crockford, David
    Primeau, Valerie
    Tibbo, Philip
    Buckley, Leslie
    Tanguay, Robert
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2024, 69 (11): : 806 - 808
  • [10] WHY SHOULD EVERY PHYSICIAN - KNOW ABOUT HEMOBILIA
    SANDBLOM, P
    WESTERN JOURNAL OF MEDICINE, 1991, 155 (06): : 660 - 660